Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Puma Biotechnology Inc (PBYI): Are Hedge Funds Right About This Stock?

Page 1 of 2

Is Puma Biotechnology Inc (NYSE:PBYI) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Puma Biotechnology Inc investors should pay attention to a decrease in enthusiasm from smart money recently. PBYI was in 18 hedge funds’ portfolios at the end of the third quarter of 2015. There were 29 hedge funds in our database with PBYI holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as United Natural Foods, Inc. (NASDAQ:UNFI), Sinclair Broadcast Group, Inc. (NASDAQ:SBGI), and Tech Data Corp (NASDAQ:TECD) to gather more data points.

Follow Puma Biotechnology Inc. (NYSE:PBYI)
Trade (NYSE:PBYI) Now!

Keeping this in mind, we’re going to take a look at the fresh action regarding Puma Biotechnology Inc (NYSE:PBYI).

What does the smart money think about Puma Biotechnology Inc (NYSE:PBYI)?

Heading into Q4, a total of 18 of the hedge funds tracked by Insider Monkey were long this stock, a change of -38% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their stakes substantially (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Adage Capital Management, managed by Phill Gross and Robert Atchinson, holds the number one position in Puma Biotechnology Inc (NYSE:PBYI). Adage Capital Management has a $428.5 million position in the stock, comprising 1.2% of its 13F portfolio. The second most bullish fund manager is Samuel Isaly of OrbiMed Advisors, with a $90.1 million position; 0.9% of its 13F portfolio is allocated to the stock. Other hedge funds and institutional investors that hold long positions comprise Columbus Circle Investors, and Steve Cohen’s Point72 Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!